• Home
  • About us
  • Our Services
  • Products
  • News
  • Contact
  • ES
Menu
  • Home
  • About us
  • Our Services
  • Products
  • News
  • Contact
  • ES
Geiser Pharma Newsletter 2022
22 de March de 2022
Benzydamine and Cetilpiridinium Lozenges
4 de January de 2023
Published by Geiser Pharma on 23 de August de 2022
Categories
  • Uncategorized
Tags
  • Cough&cold Lozenges
  • Products for out-licensing
Flurbiprofen License Out

Flurbiprofen mint&honey and lemon flavours, new products of Geiser Pharm

The success of Geiser’s Pharma Flurbiprofen Lozenges, proved with its more than 53 Marketing Authorizations granted, has led us to the development of two new flavours, honey-mint and lemon, which will allow our partners to extend their cough&cold OTC product line as well as to start new partnerships.

A product of the OTC area with high consumer’s preference that offers a pleasant taste together with an attractive indication to quickly relieve pain and fight inflammation of the throat.

Under our licensing out business model, we always seek through a win-win strategy, partnership with which we can reach license and supply agreements that boost both parties’ growth.

Know More
Share
0
Geiser Pharma
Geiser Pharma

Related posts

Geiser Pharma annual newsletter. A company specialised in the development of value added product. Don't miss out dossiers ready to be license out
4 de January de 2023

GEISOUTSIDE: END OF THE YEAR NEWSLETTER


Read more
4 de January de 2023

Benzydamine and Cetilpiridinium Lozenges


Read more
22 de March de 2022

Geiser Pharma Newsletter 2022


Read more

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Linkedin

Products

  • OTC
  • Medical devices
  • RX

Contact

Polígono Industrial Mutilva

Calle E, nº5

31192 Mutilva (Navarra, Spain)

Teléfono: +34 948 101 943

Fax: +34 948 229 090

geiserpharma@geiserpharma.com

 

Copyright © 2021, Geiser Pharma. All rights reserved - Legal notice, privacy policy and data protection | Cookies policy